Thank you all for the support and great questions we’ve been receiving over the past two weeks. Our novel technology in epigenetics is something we’re always excited to talk about; but we also believe it’s important to highlight who this technology benefits - real families.

As our CEO Rich Uhlig often puts it, “we’re a different kind of company at our core; we’re fundamentally in the service of others. That philosophy is shared by everyone at Quadrant and positively impacts everything we do.”

Several weeks back we had the opportunity to sit down and talk with a family about their journey to receive an autism diagnosis for their son. In this short clip, the mom, Amber, talks about how the biological data from the Clarifi ASD test nicely dovetailed with the behavioral observations of specialists and provided the family great clarity and confidence in the diagnosis.

Watch the clip here:

What’s more, the family was recently interviewed by Dr Max Gomez of CBS News about their personal autism journey. That interview should be airing sometime in the near future. We can’t wait to share that with you once it airs!

For more information, including information on the risks involved, please read our offering circular and supplement found here.